This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Ebola Program (RedHill/NIH)

RedHill Biopharma Ltd.

Description: RedHill and the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), are developing a proprietary experimental therapy for the treatment of Ebola virus disease.

Partners: National Institutes of Health (NIH)


Ebola Program (RedHill/NIH) News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug